Programs & Services
Swallowing Center
Hepatitis Treatment Center
Colonic Disorders
Inflammatory Bowel Disease
GI/Liver Diseases in HIV Infection
Pancreatic and Biliary Diseases
Gastroesphageal Reflux Disease (GERD)
Obscure Gastrointestinal Bleeding
Liver Center/Transplantation Program
Swallowing Center
The USC Swallowing Center conducts research and provides patient care in oropharyngeal and esophageal dysphagia. Using video esophagram, esophageal and cricopharyngeal manometry, esophageal impedance, 24- and 48-hour single and bi-probe pH studies, and endoscopy, complex swallowing disorders are diagnosed and then treated. The USC Swallowing Center is located on the 5th floor of Healthcare Consultation Center I, at 1510 San Pablo Street.
Hepatitis Treatment Center
The USC Hepatitis Treatment Center provides comprehensive disease management for patients with all forms of viral hepatitis. Patients are treated with the latest FDA-approved therapies and are evaluated for inclusion in clinical trials using investigational drug treatments.
Colonic Disorders
In conjunction with the USC departments of radiology, colorectal surgery, and oncology, USC gastroenterologists utilize a state-of-the-art program for the early diagnosis and treatment of colon cancer. This includes consultation, genetic counseling, colonoscopy, virtual colonoscopy, laparoscopic surgery, and the most recent advances in chemotherapy. We also provide consultative and treatment services for patients with irregular bowel movements. Faculty members are currently conducting research on colon cancer epidemiology, the genetic markers of colon cancer, and colonoscopy outcomes with respect to indication. Evaluation and management of hemorrhoidal disease is also offered with special emphasis on innovative, non-surgical endoscopic treatment.
Inflammatory Bowel Disease
USC’s Inflammatory Bowel Disease Program includes consultative services and a full range of endoscopic, medical, and surgical therapies. USC gastroenterologists and surgeons work together, attending a combined inflammatory bowel disease conference where they discuss their most challenging cases. The program’s research interests include novel treatments for ulcerative colitis, a chronic inflammatory disease of the digestive tract.
GI/Liver Diseases in HIV Infection
Consultation and endoscopic evaluation is available for patients living with HIV who have gastrointestinal problems such as dysphagia, bleeding, vomiting or diarrhea, pancreatic or biliary tract disorders, and liver disease, including concomitant and viral hepatitis.
Pancreatic and Biliary Diseases
Full consultative and endoscopic services are available for individuals with pancreatic and biliary diseases, including biliary pancreatitis, chronic pancreatitis, pancreatic pseudocysts, gallstone disease, biliary and pancreatic malignancies, and post-liver transplantation complications. New endoscopic techniques are available to help manage these complex cases.
Gastroesophageal Reflux Disease (GERD)
The latest consultative and endoscopic evaluations are used to manage all aspects of gastroesophageal reflux disease (GERD). These techniques include, but are not limited to, capsule esophagoscopy, wireless pH monitoring (BRAVO), manometry, and endoscopy. Ongoing research interests include the management of atypical GERD and the development of non-surgical anti-reflux procedures, including the Enteryx procedure.
Obscure Gastrointestinal Bleeding
Consultation and management of obscure bleeding is also offered using specialized techniques such as push enteroscopy and capsule endoscopy.
Liver Center/Transplantation Program
The USC Liver Center is comprised of a multidisciplinary team of hepatologists, hepato-biliary/transplant surgeons, interventional/body imaging radiologists, and pathologists. This innovative program offers a full range of consultative and evaluation services for patients with all forms of liver disease and patients who require liver transplantation. Our hepatologists have expertise in the diagnosis and management of a range of liver conditions, including viral hepatitis, alcoholic liver disease, non-alcoholic fatty liver disease, hepatocellular carcinoma, and portal hypertension complications.